Details of the Drug Reposition

General Information of This Drug (ID: DMUKK9B)

• Drug Name: C31510 (DMUKK9B)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Squamous cell carcinoma	DISQVIFL	2B60-2D01	Phase 1	[1]
Basal cell carcinoma	DIS7PYN3	2C32	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT01251562) Safety Study of Sterile Compound c31510 for Injection to Subjects With Solid Tumors. U.S. National Institutes of Health.